Full Committee Hearing Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak

Date: Thursday, November 15, 2012 Time: 09:45 AM Location: 106 Dirksen Senate Office Building

Open in New Window

Witnesses

Panel I

  1. Dr. Beth Bell
    Director, National Center for Emerging and Zoonotic Infectious Diseases
    Centers for Disease Control and Prevention
    Atlanta, GA
  2. Dr. Peggy Hamburg
    Commissioner
    Food and Drug Administration
    Washington, DC
  3. Dr. Lauren Smith
    Interim Commissioner
    Department of Public Health
    Boston, MA

Panel II

  1. Barry Cadden
    Owner and Director of Pharmacy
    New England Compounding Center
    Framingham, MA

Panel III

  1. Dr. Marion Kainer
    Director
    Healthcare Associated Infections & Antimicrobial Resistance Program, Tennessee Department of Health
    Nashville, TN
  2. David G. Miller
    Executive Vice President and CEO
    International Academy of Compounding Pharmacy
    Missouri City, TX
  3. Dr. Kasey K. Thompson
    Vice President, Office of Policy, Planning and Communications
    American Society of Health-System Pharmacists
    Bethesda, MD

Transcripts

Related Files

Other Files

Related Photos

Sen. Roberts and Sen. Harkin Sen. Enzi Sen. Alexander Sen. Roberts Sen. Franken and Peggy Hamburg The First Panelists The Third Panelists Kasey Thompson Lauren Smith Peggy Hamburg Beth Bell Marion Kainer David Miller